webinar register page

Topic

Data and Policy to Drive Access to Evidence-Based Opioid Use Disorder Treatment

Description

It is estimated that over 76,975 Americans died because of an opioid overdose in 2021. Furthermore, an estimated 2.7 million people aged 12 and older currently suffer from an opioid use disorder (OUD). Medications for OUD (MOUD) has been shown to reduce fatal overdoses and opioid use and allow recovery and restoration of healthy function. While effective treatments for OUD are available, at a national level, however, there remains barriers to accessing evidence-based treatment, as only 11.2% of all people aged 12 or older with a past year OUD received MOUD in 2020.

FORE’s first grantmaking program started in 2020 focused on promoting access to OUD treatment across the United States, with a particular focus on urban, rural, minority, tribal, and low-income communities that lack resources to meet patients and families’ needs. A number of these projects have completed the important work of generating current data on gaps in services and disparities, as well as identifying what’s most effective in reducing barriers to treatment, producing new information that can inform policymakers, payers, and providers.

Please join us on Thursday, June 23rd at 3pm EST as we welcome…

• Arjun Venkatesh, MD, MBA, MHS, Associate Professor and Chief of the Section of Administration in the Department of Emergency Medicine at Yale University
• Lisa Clemens-Cope, PhD, Senior Research Fellow in the Health Policy Center at the Urban Institute
• Peter Treitler, MSW, Research Specialist in the Center for Health Services Research at the Rutgers University Institute for Health, Health Care Policy and Aging Research
• Bradley Stein, MD, PhD, Director of the Opioid Policies, Tools, and Information Center (OPTIC) at the RAND Corporation

… as they present and react to findings from their FORE-funded projects and provide some recommendations for the field.

The webinar will run until 4:30pm to allow for an extended discussion and Q&A session.

Time

Jun 23, 2022 03:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .

All fields are required

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Jun 23, 2022 03:00 PM Eastern Time (US and Canada) Topic: Data and Policy to Drive Access to Evidence-Based Opioid Use Disorder Treatment Register in advance for this webinar: https://us02web.zoom.us/webinar/register/WN_uXBUZTypQFusxWcJtPrQ4A After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Arjun Venkatesh, MD, MBA, MHS (Associate Professor and Chief of the Section of Administration in the Department of Emergency Medicine @Yale University) Dr. Venkatesh, along with Drs. Scott Weiner and Kathryn Hawk, have been leading FORE's grant to the American College of Emergency Physicians (ACEP). ACEP is using proven quality improvement techniques and performance benchmarking to promote best practices for treating opioid use disorder in emergency departments across the U.S., a critical point of entry for patients. The goal is to make medications for opioid use disorder initiation and naloxone dispensation in emergency departments the norm. Lisa Clemens-Cope, PhD (Senior Research Fellow in the Health Policy Center @Urban Institute) Dr. Clemans-Cope has been leading FORE's grant to the Urban Institute. The Urban Institute is working to identify gaps in opioid use disorder–related services and deficits in substance use prevention, screening, and brief intervention services for low-income adolescents and young adults. It’s also helping to identify Medicaid polices that would help to eliminate them. Peter Treitler, MSW (Research Specialist in the Center for Health Services Research @Rutgers University Institute for Health, Health Care Policy and Aging Research) Mr. Treitler has been helping to lead a FORE grant to Rutgers, The State University of New Jersey. New Jersey’s Medicaid program eliminated prior authorization requirements for buprenorphine, increased reimbursement for intake assessments, and now pays for navigation and peer support services. This evaluation has assessed whether these changes have made care more accessible and improved treatment outcomes, helping to inform payers looking for ways to encourage primary care providers to offer medications for opioid use disorder. Bradley Stein, MD, PhD (Director of the Opioid Policies, Tools, and Information Center (OPTIC) @RAND Corporation) Dr. Stein is leading a FORE grant to the RAND Corporation. His project is investigating changes in buprenorphine prescribing during the pandemic and how these changes may have affected access to care and treatment outcomes among underserved populations, including Medicaid beneficiaries and rural populations. RAND is exploring how the observed changes in prescribing relate to different state policies. The analysis will inform decisions about whether to continue or adapt COVID-era policies intended to preserve access to treatment.

Time Zone:

webinar register page

Share via Email

Switch Time Zone

Upcoming Meetings